Australia to reject Viagra
This article was originally published in OTC Bulletin & The Rose Sheet
Executive Summary
Australia’s Therapeutic Goods Administration (TGA) looks set to reject an application to switch sildenafil – the active ingredient in Pfizer’s blockbuster erectile dysfunction drug Viagra – from prescription to non-prescription status.